-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Why Is Inspire Veterinary (IVP) Stock Down 25% Today?
Inspire Veterinary stock is taking a beating on Thursday after the company completed a public offering for shares of IVP.
7 High-Yield Dividend Stocks to Buy and Hold Forever: July Edition
Explore the top seven high-yield dividend stocks, leading in several industries to buy and hold for income stability.
Top Pot Picks: 3 Unstoppable Cannabis Stocks Set to Blaze Past Competition
These are the cannabis stocks to buy as they represent companies with good fundamentals and a robust growth outlook
3 Dirt-Cheap Drug Developers With Blockbuster Potential
These are three of the best cheap drug developer stocks for investors to keep an eye as their growth could be imminent.
The 7 Most Undervalued Dividend Stocks to Buy in July 2024
For nearly 100 years income stocks have outperformed the market and these three undervalued dividend stocks are your best buys this month.
Stocks to Buy: 3 Breakout Stars to Transform Your Portfolio
Although breakout stocks present high risks, the underlying lack of predictability provides fuel for tremendous upside.
3 Growth Stocks No One Is Watching (But They Should Be)
While overlooked growth stocks present high risks, it’s difficult to find any other sector with as much upside potential.
3 Stocks to Avoid Like the Plague in 2024
Avoid these three stocks like the plague in 2024 to protect your portfolio from potential pitfalls and losses.
3 Once-in-a-Lifetime Stocks to Buy Now: July 2024
Investing in the stock market can be daunting, but finding top stocks to buy can offer considerable rewards.
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
These are the healthcare stocks to buy as they represent companies with good fundamentals, stable growth visibility and cash flow upside.
Why Is Kazia Therapeutics (KZIA) Stock Up 300% Today?
Kazia Therapeutics stock is heading higher on Wednesday as KZIA investors celebrate positive clinical trial news from the company.
Why Is Virpax Pharmaceuticals (VRPX) Stock Up 98% Today?
Virpax Pharmaceuticals stock is up on Wednesday as VRPX shareholders celebrate successful results from a swine model study.
Why Is Longeveron (LGVN) Stock Up 53% Today?
Longeveron stock is up on Wednesday as LGVN investors react to the company's Alzheimer’s treatment being granted RMAT designation.
3 Undervalued Stocks Set to Outperform the Market in 2024
Discover the top three undervalued stocks poised for growth in the restaurant, pharmaceutical and footwear industries.
Biotech Bombshell: G1 Therapeutics Stock Is Too Much of a Gamble
G1 Therapeutics stock is highly volatile, and investors should be wary now as G1 Therapeutics recently failed to achieve a clinical goal.
Stay Away: Why Ginkgo Bioworks Stock Is Not for the Faint-Hearted
Ginkgo Bioworks stock is down, but this doesn't mean it's a bargain as Ginkgo Bioworks faces a serious delisting threat.
5 Investors Betting Big on Soligenix (SNGX) Stock
SNGX stock is elevating higher after Soligenix released positive results from its HyBryte study. Here are the company's top investors.
Hot Stocks: 3 Sleeping Giants About to Dominate Their Sectors
Give some consideration to these names, each of which has a strong competitive advantage and catalysts driving their share price higher.
Why Is uniQure (QURE) Stock Up 51% Today?
UniQure stock is up on Tuesday as QURE investors react to positive clinical trial data for its Huntington’s disease treatment candidate.